Japanese stem-cell 'breakthrough' findings retracted By

New Post Public Reply Private Reply Replies (1) Message Board
Ospreyeye
Japanese stem-cell 'breakthrough' findings retracted
By James Gallagher

http://www.bbc.com/news/health-28124749

Research into one of the biggest recent stem-cell "breakthroughs" has been withdrawn because of "critical errors".

Scientists in Japan had claimed stem cells could be made cheaply, quickly and ethically just by dipping blood cells into acid.

They have now written a retraction that apologises for "multiple errors" in their report.

Nature, the journal that published the findings, is reviewing how it checks scientific papers.

Stem cells can become any other type of tissue and are already being investigated to heal the damage caused by a heart attack and to restore sight to the blind.

Researchers around the world described the acid-bath stem-cell finds as a "game changer," "remarkable" and "a major scientific discovery".

Falling apart
However, errors were rapidly discovered, parts were lifted from early work and presented as though it was new research, and leading scientists have been unable to produce stem cells using acid in their own laboratories.

An investigation by the Riken research institute in Japan found that scientist Dr Haruko Obokata had fabricated her work in an intentionally misleading fashion.

The retraction states: "These multiple errors impair the credibility of the study as a whole and we are unable to say without doubt whether the stimulus-triggered acquisition of pluri­potency stem cells phenomenon is real.

"Ongoing studies are investigating this phenomenon afresh, but given the extensive nature of the errors currently found we consider it appropriate to retract both papers."

The affair brings back memories of the false claims by world-renowned cloning scientists Hwang Woo-suk.

He claimed he had produced embryonic stem cells from cloned human embryos, but those findings were later found to be "intentionally fabricated".

'Highlighted flaws'
Jump media playerMedia player helpOut of media player. Press enter to return or tab to continue.
Archive: Dr Haruko Obokata presented the "breakthrough" findings in January
A Nature editorial stated that the public's trust in science was at stake in the latest controversy.

It added: "Although editors and referees could not have detected the fatal faults in this work, the episode has further highlighted flaws in Nature's procedures and in the procedures of institutions that publish with us."

However, it did say a review was under way to increase checking on images used in papers.

The acid-bath stem cells research has not been completely discredited and research is continuing to see if stem cells can be produced using the method.

Chris Mason, a professor of regenerative medicine at University College London, originally said the results were "a very exciting, but surprise, finding" and added: "It looks a bit too good to be true."

After the retraction, he told the BBC: "I'm surprised that Nature took so long when there was so much material showing problems with the papers. I don't understand that."

However, he said the system of peer review, in which fellow scientists critique papers before they are published, would struggle to pick up the problems in this research.

He said: "If you're a reviewer you can only review the material you're given. You have to take it on trust. You're not a detective looking for fraud.

'Good day for science'
"If you have to act as a super-sleuth, that's impossible for anyone to ever do."

He praised the way social media had uncovered and shared the errors, which could have otherwise taken years to unpick.

"I would argue this is not an embarrassing day for science, I think it's a good day for science and it shows we work well to weed out inferior publications."

Dr Dusko Ilic, a senior lecturer in stem-cell science at King's College London, said: "It is easy to be judgmental, and pointing fingers after all is over.

"Gaining knowledge is difficult. It requires both time and persistence, I hoped that Haruko Obokata would prove at the end all those naysayers wrong.

"Unfortunately, she did not. The technology, indeed, sounded too good to be true, though I still find fascinating how a 30-year-old scientist could pass scrutiny of her co-workers and multiple reviewers in Nature with a complete fabrication."

The UK Medical Research Council's Prof Robin Lovell-Badge added: "The stem cell community has been expecting these retractions to come for a while.

"This story illustrates how the stem cell field can rapidly detect bad science and reject it.

"It also illustrates both the problems and benefits of hype, this was potentially important research because of the novelty of the claims in an important field, but it was hyped far beyond reality, by some of the authors and by their perhaps willing victims, the media."
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hair Syrup's Big U.S. Leap: Target Welcomes Viral Brand

Updated Category News Views 2

From Kitchen Experiment to U.S. Debut Here's a story that barely fits the tight mold of your typical business textbook. Hair Syrup, born from the brain of a university student tinkering at her kitchen table, is about to make waves across the pond. Lucie Macleod did what many dream of—she took a DIY hair oil project and spun it into a multimillion-dollar brand, now set...

Continue Reading
Health Net's $2M Boost for Stanislaus Affordable Housing

Updated Category News Views 1

Joining the Fight Against California’s Housing Crisis Well, I'll be the first to say it's a breath of fresh air when a healthcare beast like Health Net starts investing in something as critical as affordable housing. This is no drop in the bucket—two million dollars is quite the commitment to fix some of the mess that’s been brewing in Stanislaus County, California....

Continue Reading
Sacrifice Unending: 9/11's Lingering Health Toll

Updated Category News Views 0

The Unseen Toll of 9/11 on the Firefighter Community Two and a half decades since that fateful morning of September 11, 2001, we're staring at a grim reality. The heroic souls of the New York City Fire Department (FDNY)—those who ran toward peril when others ran away—are still paying the price. Incredibly, more than 400 FDNY members have succumbed to World Trade...

Continue Reading
Woodpack Global Unveils Crate Design System: A New Era Begins

Updated Category News Views 1

Innovating the Wooden Crate Landscape An old industry got a much-needed facelift today, folks. Woodpack Global has rolled out Crate Design System™ (CDS)—a snazzy new tool that's shaking up the wooden crate design landscape. It blows the dust off outdated design methods that have been collecting cobwebs since the '60s. That's right, we’re talking about a significant...

Continue Reading
Shareholder Rights in Focus: Examining Key Buyouts

Updated Category News Views 0

Shareholder Concerns Rise Amid Corporate Buyouts The stakes are high for the shareholders of Distribution Solutions Group, Eagle Financial Services, Safety Insurance Group, and Utz Brands as their companies face potential buyouts. Let's chew over what's on the table: the sweet deals insiders might score and the legal maneuvers in play. Halper Sadeh LLC, a heavy-hitting...

Continue Reading
Push Notification Security Transforms Healthcare IT Support

Updated Category News Views 1

Cutting the Fat on IT Help Desk Bottlenecks Healthcare IT teams are fighting an uphill battle with password resets, a mundane task consuming up to half of all help desk calls. It's like trying to stop a leaking dam with duct tape. For health systems, these calls aren't just a minor annoyance—they're a full-fledged budget hog. Try telling a CIO that an agent-friendly...

Continue Reading
Aflac's $200M Milestone in Cancer Charity Support

Updated Category News Views 0

Pioneering Efforts Across Decades Here’s an effort that bucks the usual corporate talk. Aflac, the supplemental insurance giant, isn’t just mumbling about its mission; it's doing the heavy lifting in the fight against childhood cancer and blood disorders. With over $200 million in contributions poured into the cause over more than 30 years, they're putting the capital...

Continue Reading
EFSI Shareholders on Alert Amid M&A Deal Scrutiny

Updated Category News Views 3

Eagle Financial Services Under the Microscope A buzz is picking up in the world of mergers and acquisitions, and this time, it's Eagle Financial Services, Inc. (NASDAQ: EFSI) caught in the crosshairs. What's the chatter all about? Well, it looks like Juan Monteverde and his crew over at Monteverde & Associates PC have set their sights on Eagle's proposed sale to John...

Continue Reading
RevSystems Joins Elite OpenAI Partner Network

Updated Category News Views 1

RevSystems Inks Deal with OpenAI Partner Network In the latest shuffle of the AI advisory deck, RevSystems just found itself elbowing into the exclusive OpenAI Partner Network. Based out of New York, RevSystems has carved a niche by spinning tech wizardry into tangible business results. Their new status as an OpenAI Select Partner puts them on a playing field where AI...

Continue Reading
CUBEX Lights Up Veterinary Care with Mini Essential

Updated Category News Views 5

Inventory Woes? Meet Mini Essential If you’ve ever worked in or around veterinary hospitals, you know the old-school headaches of managing controlled substances. Picture this: piles of paper logs, end-of-shift recounting, and inevitable discrepancies that rear their ugly heads long after closing time. Enter CUBEX, shaking things up with their latest launch, Mini...

Continue Reading

Top 5 Most Recently Viewed Articles

Alphyn Biologics Launches Groundbreaking Atopic Dermatitis Trial

Updated Category News Views 324

Alphyn Biologics Unveils Innovative Clinical Trial for Atopic Dermatitis Treatment Alphyn Biologics, Inc. is making strides in its mission to address the complexities of atopic dermatitis (AD) by launching the CLEAR-AD1 Phase 2b clinical trial program. Leading this initiative is their cutting-edge product, Zabalafin Hydrogel, which is designed to effectively target the...

Continue Reading
CoreWeave Faces Market Struggles Amid AI Demand Surge

Updated Category News Views 120

CoreWeave Inc Experiences Major Stock Drop CoreWeave Inc (NASDAQ: CRWV) has seen its stock plummet by nearly 10% in pre-market trading, marking a significant moment for the company. The drop comes despite the firm reporting strong second-quarter revenue that outstrips projections. However, the downside appears to be linked to disappointing earnings per share (EPS), which...

Continue Reading
DeepSeek's Impact on AI: Rethinking Market Dynamics

Updated Category News Views 326

Understanding DeepSeek's Revolutionary AI Tools In today's rapidly evolving technological landscape, a recent development has the potential to change the rules of the game. While debates about software consuming the world continue, it's crucial to delve into the implications of DeepSeek's innovative approach. This situation may echo the historical context of the Soviet...

Continue Reading
Strategic Communications Secures Major National Contract

Updated Category News Views 123

Strategic Communications Awarded National Sourcewell Contract Strategic Communications has recently achieved a vital milestone by securing a national Sourcewell contract tailored specifically for Public Safety Software-as-a-Service (SaaS), Infrastructure-as-a-Service (IaaS), Platform-as-a-Service (PaaS), and various other professional technology services. This cooperative...

Continue Reading
Porter's Innovative Care Solutions Transform Member Health

Updated Category News Views 312

Porter Simplifying Health Care Coordination Porter has emerged as a pioneering force in AI-driven care coordination and comprehensive clinical services at home. With a focus on Medicare Advantage, ACA Commercial, and Medicaid plans, Porter stands out as an essential in-home vendor. By integrating care coordination, in-home visits, and advanced analytics, this innovative...

Continue Reading